Diabetes
Novo Nordisk shares positive results from COMBINE 3 phase 3a trial
January 10, 2024Research and Development Diabetes, IcoSema, Novo Nordisk, clinical trial, diabetes
Novo Nordisk has shared topline results from the COMBINE 3 phase 3a trial of once-weeklly IcoSema, a fixed-ration combination treatment …
Eli Lilly launches digital healthcare process
January 5, 2024Medical Communications Diabetes, Eli Lilly, Obesity, diabetes, obesity
Eli Lilly has announced its new digital healthcare experience, LillyDirect, which will benefit patients in the US with obesity, migraine …
Abbott to acquire Bigfoot Biomedical
September 6, 2023Business Services Abbott, Bigfoot Biomedical, Diabetes, acquisition, diabetes
Abbott and Bigfoot Biomedical have announced a definitive agreement for Abbott to acquire Bigfoot, however this transaction is still subject …
First cellular therapy for patients with type 1 diabetes approved by FDA
June 29, 2023Medical Communications Diabetes, FDA, Lantidra, Type 1 diabetes, diabetes
The US Food and Drug Administration (FDA) has announced that it has approved Lantidra, the first allogeneic (donor) pancreatic islet …
AstraZeneca’s Xigduo XR approved in China for adults with type-2 diabetes
June 27, 2023Medical Communications AstraZeneca, China, Diabetes, Xigduo XR, diabetes
AstraZeneca has announced that its Xigduo XR (dapagliflozin and metformin hydrochloride extended-release), a once-daily fixed-dose combination, has now been approved …
FDA approves new medicines to treat paediatric type 2 diabetes
June 22, 2023Medical Communications Diabetes, FDA, Synjardy, jardiance, paediatrics, type 2 diabetes
The US Food and Drug Administration (FDA) has announced that it has approved Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin …
Latest content
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
